Effects of Dietary Nitrate Intake on Physical Performance of Middle-aged Women
Effects of Dietary Nitrate Intake on Physical Performance of Middle-aged Women: a Randomized Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
SP
-
Ribeirao Preto, SP, Brazil, 05508-900
- Recruiting
- Cicero Jonas Rodrigues Benjamim
-
Contact:
- Cicero JR Benjamim
- Phone Number: 07775453372
- Email: jonasbenjamim@usp.br
-
-
São Paulo
-
Ribeirão Preto, São Paulo, Brazil
- Recruiting
- EEFERP - USP / Laboratório de Fisiologia do Exercício e Metabolismo
-
Contact:
- Cicero Jonas R. Benjamim, PhD Student
- Phone Number: 87988621194
- Email: benjamim.nutricao@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 50 to 65 years old
- Physically inactive
- Postmenopausal diagnosis (amenorrhea for 12 months or more);
Exclusion Criteria:
- Smoking
- Cardiac failure
- Previous history of acute myocardial infarction and/or stroke;
- Allergy or intolerance to nitrate, gluten, or milk;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Experimental (Beetroot juice NO3)
8-day supplementation with beetroot juice rich in NO3 (400mg) during 8 days.
|
The participant will intake beetroot juice rich in NO3 (400mg) during 8-days.
On the eighth day of the intervention, 2 hours after intake the last bottle of juice, the participants will return to the laboratory for the performance tests evaluation.
Before crossover protocol a 7-day washout interval will be given for the purification of the compounds provided by the protocols.
|
|
Placebo Comparator: Placebo (Beetroot juice without NO3)
8-day supplementation with beetroot juice NO3 depleted during 8 days.
|
The participant will intake beetroot juice depleted in NO3.
On the eighth day of the intervention, 2 hours after intake the last bottle of juice, the participants will to the laboratory for the performance tests evaluation.
Before crossover protocol a 7-day washout interval will be given for the purification of the compounds provided by the protocols.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Handgrip strength test (kgf)
Time Frame: up to 2 years
|
up to 2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Six minute walk test (distance in meters)
Time Frame: up to 2 years
|
up to 2 years
|
|
Arm curl test (repetitions)
Time Frame: up to 2 years
|
up to 2 years
|
|
Sit-to-stand test (repetitions)
Time Frame: up to 2 years
|
up to 2 years
|
|
8-foot up and go test (seconds)
Time Frame: up to 2 years
|
up to 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BEET-MS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.